Open menu
Paytm Money logo
Download App
SBI Mutual Fund

SBI Healthcare Opportunities Fund Direct Plan-Growth

NAV
returns change indicator
130.1353
as on 18 Apr 2019 09:30 PM
-0.4439(0.34%)
Last Change
Scheme Ratings
medal
2
Pharma
by returns in last 5 years
Schemes Managed By
Investment Performance
would have given a returns of
110,871
star
121,647
star
87,250
star
90,442
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
9,558
Profit (absolute return)
9.56%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
0.86%
In the last 6 months
0.18%
In the last 1 year
2.00%
In the last 3 years
9.56%
In the last 5 years
60.33%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
SBI Healthcare Opportunities Fund Direct Plan-Growth
SBI Healthcare Opportunities Fund Direct Plan-Growth
as of 18 Apr 2019 09:30 PM
1,029.91 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.50% if redeemed within 15 days
1.24%
Expense Ratio
Plan
Growth
2.29%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 0.50% if redeemed within 15 days
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Mar 2019
Sort By
Healthcare
95.35%
982.02 Cr
Cash Holding
2.29%
23.59 Cr
Sectors Holding in this Mutual Fund
as on 31 Mar 2019
Sort By
Healthcare
95.35%
982.02 Cr
Cash Holding
2.29%
23.59 Cr
Companies Holding in this Mutual Fund
as on 31 Mar 2019
Sort By
Aurobindo Pharma Ltd.
10.66%
109.79 Cr
Divi's Laboratories Ltd.
10.56%
108.76 Cr
Dr. Reddy's Laboratories Ltd.
9.98%
102.79 Cr
Strides Pharma Science Ltd.
8.40%
86.51 Cr
Lupin Ltd.
8.38%
86.31 Cr
Sun Pharmaceutical Inds. Ltd.
5.88%
60.56 Cr
Torrent Pharmaceuticals Ltd.
5.03%
51.80 Cr
Biocon Ltd.
4.96%
51.08 Cr
Others
4.65%
47.89 Cr
Alkem Laboratories Ltd.
4.18%
43.05 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Mar 2019
Sort By
Aurobindo Pharma Ltd.
10.66%
109.79 Cr
Divi's Laboratories Ltd.
10.56%
108.76 Cr
Dr. Reddy's Laboratories Ltd.
9.98%
102.79 Cr
Strides Pharma Science Ltd.
8.40%
86.51 Cr
Lupin Ltd.
8.38%
86.31 Cr
Sun Pharmaceutical Inds. Ltd.
5.88%
60.56 Cr
Torrent Pharmaceuticals Ltd.
5.03%
51.80 Cr
Biocon Ltd.
4.96%
51.08 Cr
Others
4.65%
47.89 Cr
Alkem Laboratories Ltd.
4.18%
43.05 Cr
View All
View All
About SBI Healthcare Opportunities Fund Direct Plan-Growth
SBI Healthcare Opportunities Fund Direct Plan-Growth is a Equity mutual fund scheme from SBI Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Tanmaya Desai. It has an AUM of ₹1,029.91 Crores and the latest NAV decalared is ₹130.135 as on 18 Apr 2019 at 9:30 pm.
SBI Healthcare Opportunities Fund Direct Plan-Growth scheme return performance in last 1 year is 2.00%, in last 3 years is -9.56% and 116.17% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Objective
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
AMC Information
SBI Mutual Fund
SBI Mutual Fund
View AMC Details
279,176.32 Cr
AUM
143
Schemes
Address
Address
9th Floor-Crescenzo, C-38 & 39-G Block, Bandra-Kurla Complex,Bandra (East)400051
Phone Number
Phone Number
Phone : 022 - 61793000 / 1800 425 5425
Fax : 022 - 22189663